BioNTech SE ADR sell Sargnagel
Start price
05.08.21
/
0%
€337.70
Target price
05.08.22
-
Performance (%)
-14.27%
End price
08.09.21
€289.50
Summary
This prediction ended on 08.09.21 with a price of €289.50. The price of BioNTech SE ADR decreased from the start of the prediction. Compared to the start price this resulted in a performance of -14.27%.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
| iShares Core DAX® | -2.196% | -0.532% | 12.492% |
| iShares Nasdaq 100 | -0.074% | 1.843% | 40.598% |
| iShares Nikkei 225® | -2.154% | -1.109% | 22.295% |
| iShares S&P 500 | -0.501% | 1.475% | 28.278% |
According to Sargnagel what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Growths faster than the competition
Innovative
Known brand
Top 10 in its market
Standard Investments for future growth
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Some uniques
Cons
Higher risks for its business
Comments by Sargnagel for this prediction
In the thread Biontech SE diskutieren
Der Kurs ist zu stark gestiegen. Wenn alle denken es geht so weiter, dann ……
In the thread Trading Biontech SE
Stopped prediction by Sargnagel for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€289.50
08.09.21
08.09.21
€333.00
08.09.22
08.09.22
-49.48%
09.09.22
09.09.22
Could be worthwhile Investment >10% per year
Capable Management
Growths faster than the competition
Higher risks for its business
